SK46797A3 - New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use - Google Patents

New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use Download PDF

Info

Publication number
SK46797A3
SK46797A3 SK467-97A SK46797A SK46797A3 SK 46797 A3 SK46797 A3 SK 46797A3 SK 46797 A SK46797 A SK 46797A SK 46797 A3 SK46797 A3 SK 46797A3
Authority
SK
Slovakia
Prior art keywords
leu
pro
cys
ile
gly
Prior art date
Application number
SK467-97A
Other languages
English (en)
Slovak (sk)
Inventor
Hakan Bergstrand
Tomas Eriksson
Kostas Karabelas
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK46797A3 publication Critical patent/SK46797A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK467-97A 1994-10-14 1995-10-06 New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use SK46797A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
SK46797A3 true SK46797A3 (en) 1997-09-10

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
SK467-97A SK46797A3 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use

Country Status (20)

Country Link
US (2) US6103697A (xx)
EP (1) EP0783519A1 (xx)
JP (1) JPH10507448A (xx)
AU (1) AU705364B2 (xx)
BR (1) BR9509345A (xx)
CA (1) CA2201479A1 (xx)
CZ (1) CZ111997A3 (xx)
EE (1) EE9700087A (xx)
FI (1) FI971499A (xx)
HU (1) HUT77118A (xx)
IL (1) IL115509A0 (xx)
IS (1) IS4459A (xx)
MX (1) MX9702666A (xx)
NO (1) NO971625L (xx)
PL (1) PL319631A1 (xx)
SE (1) SE9403526D0 (xx)
SK (1) SK46797A3 (xx)
TR (1) TR199501255A2 (xx)
WO (1) WO1996011943A1 (xx)
ZA (1) ZA958140B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
JP2000508898A (ja) * 1996-04-12 2000-07-18 アストラ・アクチエボラーグ 免疫調節作用を有するシステイン―含有またはメチオニン―含有ペプチド
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
WO1999062483A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
EP1948782B8 (en) 2005-04-25 2012-09-12 Cadila Pharmaceuticals Limited Vaccine adjuvants
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
JPH01501939A (ja) 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
EP0548200B1 (en) 1990-09-11 1999-04-14 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
DE69233772D1 (de) 1991-10-16 2009-11-12 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
KR960700739A (ko) 1993-03-05 1996-02-24 카린 이스텀 Hla-a2. 1 결합 펩티드 및 그의 용도(hla-a2. 1 binding peptides and their uses)
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
AP690A (en) 1994-07-05 1998-10-16 Steeno Res Group A/S Immunomodulators based on a polypeptide other than human interleukin 10.
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
HUT77118A (hu) 1998-03-02
FI971499A0 (fi) 1997-04-10
AU3713395A (en) 1996-05-06
FI971499A (fi) 1997-06-10
IS4459A (is) 1997-04-08
MX9702666A (es) 1997-06-28
EE9700087A (et) 1997-10-15
IL115509A0 (en) 1996-05-14
PL319631A1 (en) 1997-08-18
US6228374B1 (en) 2001-05-08
EP0783519A1 (en) 1997-07-16
NO971625D0 (no) 1997-04-09
TR199501255A2 (tr) 1996-06-21
AU705364B2 (en) 1999-05-20
ZA958140B (en) 1997-06-27
BR9509345A (pt) 1997-11-25
WO1996011943A1 (en) 1996-04-25
SE9403526D0 (sv) 1994-10-14
NO971625L (no) 1997-05-30
JPH10507448A (ja) 1998-07-21
CZ111997A3 (en) 1997-12-17
CA2201479A1 (en) 1996-04-25
US6103697A (en) 2000-08-15

Similar Documents

Publication Publication Date Title
SK46797A3 (en) New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
JP2514518B2 (ja) ヘプタペプチドおよびオクタペプチドのソマトスタチン類似アミド誘導体、それを含有する抗腫瘍剤
IE41510B1 (en) Peptides having lh-rh/fsh-rh activity and proces for their manufacture
CA3073806A1 (en) Opioid agonist peptides and uses thereof
CA2399187C (en) Kahalalide compounds
WO2004020462A1 (ja) Ｃｘｃｒ４拮抗薬およびその用途
JPH03504013A (ja) Ｔ細胞ヘルパー活性を有するペプチド
HU203563B (en) Process for producing opioid-polypeptides and pharmaceutical compositions containing them
AU602483B2 (en) Immunoregulatory peptides
MXPA97002666A (en) New peptides with immunoregulated effects
JP3178835B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
AU641366B2 (en) Peptide compounds
JPH02500517A (ja) ペプチド化合物
CA2173939C (en) Oligopeptides derived from c-reactive protein fragments
US4684622A (en) Compositions and methods for producing vasodilation and antioxytocic activity
US4599324A (en) V1-vasopressin antagonists
HU201964B (en) Process for producing peptides inhibiting maturation of t-lymphocytes and activity of macrophages, as well as pharmaceutical compositions comprising same
Manning et al. Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids
CA2098535A1 (en) Linear peptides
JP4781621B2 (ja) Ｃｘｃｒ４拮抗薬およびその用途
EP2051991B1 (en) Cardioprotective compounds
CN117645651A (zh) 一种环肽类抗肿瘤活性化合物及药物组合物与应用
JPS63303999A (ja) バソプレシン拮抗剤
JPH07242563A (ja) ガン転移抑制剤